A Pioneer in Ageing Research Dr David Sinclair is a Professor of Genetics at Harvard Medical School and a leading researcher in the field of ageing
Several key developments in the drug pipeline could impact current trends and ultimately drive competition for these innovative medications
Given these findings, further analyses are required to identify the interaction between microbial alterations by rifaximin and the therapeutic effects in the current model
Oral peptides face significant bioavailability challenges due to gastrointestinal degradation, though formulation advances are improving this limitation
This indicates excellent customer satisfaction on quality and service for decorative, message-driven products
Melasma is known for recurring, particularly with sun exposure, heat, and hormonal shifts, and the American Academy of Dermatology notes it can persist for years